Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 18583 | 545 | 39.0 | 83% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 389 | 3 | PEROXISOME//CARNITINE//JOURNAL OF INHERITED METABOLIC DISEASE | 30841 |
| 1504 | 2 | CARNITINE//L CARNITINE//TRIMETAZIDINE | 7543 |
| 18583 | 1 | RANOLAZINE//LATE SODIUM CURRENT//LATE I NA | 545 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | RANOLAZINE | authKW | 8579926 | 36% | 77% | 198 |
| 2 | LATE SODIUM CURRENT | authKW | 2116148 | 9% | 79% | 48 |
| 3 | LATE I NA | authKW | 560270 | 2% | 100% | 10 |
| 4 | LATE NA CURRENT | authKW | 400187 | 2% | 71% | 10 |
| 5 | CARDIOVASC THER EUT AREA | address | 394512 | 2% | 54% | 13 |
| 6 | CARDIOELE OPHYSIOL | address | 366712 | 2% | 55% | 12 |
| 7 | CARISA | authKW | 168081 | 1% | 100% | 3 |
| 8 | F 15845 | authKW | 168081 | 1% | 100% | 3 |
| 9 | ASPIRUS HEART VASC | address | 112054 | 0% | 100% | 2 |
| 10 | LATE I NA CURRENT INHIBITOR | authKW | 112054 | 0% | 100% | 2 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Cardiac & Cardiovascular System | 10772 | 55% | 0% | 299 |
| 2 | Pharmacology & Pharmacy | 1556 | 32% | 0% | 176 |
| 3 | Peripheral Vascular Diseases | 461 | 9% | 0% | 50 |
| 4 | Physiology | 317 | 9% | 0% | 50 |
| 5 | Chemistry, Medicinal | 34 | 3% | 0% | 17 |
| 6 | Cell Biology | 23 | 6% | 0% | 30 |
| 7 | Integrative & Complementary Medicine | 22 | 1% | 0% | 5 |
| 8 | Engineering, Biomedical | 10 | 2% | 0% | 9 |
| 9 | Biochemical Research Methods | 7 | 2% | 0% | 12 |
| 10 | Health Care Sciences & Services | 5 | 1% | 0% | 6 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CARDIOVASC THER EUT AREA | 394512 | 2% | 54% | 13 |
| 2 | CARDIOELE OPHYSIOL | 366712 | 2% | 55% | 12 |
| 3 | ASPIRUS HEART VASC | 112054 | 0% | 100% | 2 |
| 4 | CARDIO ELE OPHYSIOL | 74701 | 0% | 67% | 2 |
| 5 | ADULT CARDIIOL | 56027 | 0% | 100% | 1 |
| 6 | ARNOLD MARIE WARZ PHARM HLTH SCI | 56027 | 0% | 100% | 1 |
| 7 | BIOL CARDIOVASC THER EUT AREA | 56027 | 0% | 100% | 1 |
| 8 | CARDIAC ARRHYTHMIA CARDIOVASC DIS | 56027 | 0% | 100% | 1 |
| 9 | CARDIO ELE OPHYS | 56027 | 0% | 100% | 1 |
| 10 | CARDIO ELECTPHYSIOL | 56027 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | HEART RHYTHM | 16068 | 5% | 1% | 29 |
| 2 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS | 9541 | 2% | 2% | 10 |
| 3 | CARDIOVASCULAR DRUGS AND THERAPY | 3483 | 2% | 1% | 11 |
| 4 | EUROPEAN HEART JOURNAL SUPPLEMENTS | 3479 | 1% | 1% | 8 |
| 5 | AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS | 3317 | 1% | 1% | 5 |
| 6 | JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 3094 | 3% | 0% | 19 |
| 7 | REVIEWS IN CARDIOVASCULAR MEDICINE | 2733 | 1% | 1% | 4 |
| 8 | AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1779 | 4% | 0% | 20 |
| 9 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1626 | 3% | 0% | 18 |
| 10 | CARDIOVASCULAR THERAPEUTICS | 1117 | 1% | 1% | 3 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | RANOLAZINE | 8579926 | 36% | 77% | 198 | Search RANOLAZINE | Search RANOLAZINE |
| 2 | LATE SODIUM CURRENT | 2116148 | 9% | 79% | 48 | Search LATE+SODIUM+CURRENT | Search LATE+SODIUM+CURRENT |
| 3 | LATE I NA | 560270 | 2% | 100% | 10 | Search LATE+I+NA | Search LATE+I+NA |
| 4 | LATE NA CURRENT | 400187 | 2% | 71% | 10 | Search LATE+NA+CURRENT | Search LATE+NA+CURRENT |
| 5 | CARISA | 168081 | 1% | 100% | 3 | Search CARISA | Search CARISA |
| 6 | F 15845 | 168081 | 1% | 100% | 3 | Search F+15845 | Search F+15845 |
| 7 | LATE I NA CURRENT INHIBITOR | 112054 | 0% | 100% | 2 | Search LATE+I+NA+CURRENT+INHIBITOR | Search LATE+I+NA+CURRENT+INHIBITOR |
| 8 | LATE SODIUM CHANNEL CURRENT | 112054 | 0% | 100% | 2 | Search LATE+SODIUM+CHANNEL+CURRENT | Search LATE+SODIUM+CHANNEL+CURRENT |
| 9 | RANEXA | 112054 | 0% | 100% | 2 | Search RANEXA | Search RANEXA |
| 10 | ANGINA | 96676 | 8% | 4% | 44 | Search ANGINA | Search ANGINA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | KEATING, GM , (2013) RANOIAZINE A REVIEW OF ITS USE AS ADD-ON THERAPY IN PATIENTS WITH CHRONIC STABLE ANGINA PECTORIS.DRUGS. VOL. 73. ISSUE 1. P. 55-73 | 64 | 94% | 9 |
| 2 | GUPTA, T , KHERA, S , KOLTE, D , ARONOW, WS , IWAI, S , (2015) ANTIARRHYTHMIC PROPERTIES OF RANOLAZINE: A REVIEW OF THE CURRENT EVIDENCE.INTERNATIONAL JOURNAL OF CARDIOLOGY. VOL. 187. ISSUE . P. 66 -74 | 59 | 82% | 15 |
| 3 | SOSSALLA, S , MAIER, LS , (2012) ROLE OF RANOLAZINE IN ANGINA, HEART FAILURE, ARRHYTHMIAS, AND DIABETES.PHARMACOLOGY & THERAPEUTICS. VOL. 133. ISSUE 3. P. 311 -323 | 57 | 76% | 40 |
| 4 | MAIER, LS , SOSSALLA, S , (2013) THE LATE NA CURRENT AS A THERAPEUTIC TARGET: WHERE ARE WE?.JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. VOL. 61. ISSUE . P. 44 -50 | 53 | 75% | 9 |
| 5 | HAWWA, N , MENON, V , (2013) RANOLAZINE: CLINICAL APPLICATIONS AND THERAPEUTIC BASIS.AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS. VOL. 13. ISSUE 1. P. 5-16 | 56 | 71% | 8 |
| 6 | MASON, FE , SOSSALLA, S , (2017) THE SIGNIFICANCE OF THE LATE NA+ CURRENT FOR ARRHYTHMIA INDUCTION AND THE THERAPEUTIC ANTIARRHYTHMIC POTENTIAL OF RANOLAZINE.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS. VOL. 22. ISSUE 1. P. 40 -50 | 66 | 57% | 0 |
| 7 | CARBONE, F , MONTECUCCO, F , MACH, F , (2013) UPDATE ON EVIDENCE FOR TREATMENT WITH RANOLAZINE IN STABLE ANGINA.SWISS MEDICAL WEEKLY. VOL. 143. ISSUE . P. - | 49 | 83% | 0 |
| 8 | KEATING, GM , (2008) RANOLAZINE A REVIEW OF ITS USE IN CHRONIC STABLE ANGINA PECTORIS.DRUGS. VOL. 68. ISSUE 17. P. 2483-2503 | 48 | 92% | 15 |
| 9 | BANERJEE, K , GHOSH, RK , KAMATAM, S , BANERJEE, A , GUPTA, A , (2017) ROLE OF RANOLAZINE IN CARDIOVASCULAR DISEASE AND DIABETES: EXPLORING BEYOND ANGINA.INTERNATIONAL JOURNAL OF CARDIOLOGY. VOL. 227. ISSUE . P. 556 -564 | 46 | 77% | 0 |
| 10 | REMME, CA , WILDE, AAM , (2013) LATE SODIUM CURRENT INHIBITION IN ACQUIRED AND INHERITED VENTRICULAR (DYS)FUNCTION AND ARRHYTHMIAS.CARDIOVASCULAR DRUGS AND THERAPY. VOL. 27. ISSUE 1. P. 91 -101 | 53 | 69% | 6 |
Classes with closest relation at Level 1 |